Q32 Bio Inc.QTTBNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-66.10M
Near historical average
Average (8y)
$-65.48M
Historical baseline
Range
High:$-10.00M
Low:$-130.26M
CAGR
+26.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-66.10M | -37.0% |
| 2023 | $-48.26M | -23.0% |
| 2022 | $-39.23M | +59.1% |
| 2021 | $-95.95M | +26.3% |
| 2020 | $-130.26M | -18.5% |
| 2019 | $-109.94M | -83.5% |
| 2018 | $-59.93M | -102.1% |
| 2017 | $-29.66M | -196.6% |
| 2016 | $-10.00M | - |